(Q88205478)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

meta-analysis

0 references

title

Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

1 reference

venous thromboembolism

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Jack Ansell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

1 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Thrombolysis

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

155-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis

21 March 2020

cites work

1 reference

12 December 2020

Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor.

1 reference

12 December 2020

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

1 reference

12 December 2020

Indirect comparisons of competing interventions

1 reference

12 December 2020

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis

1 reference

12 December 2020

Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor xa inhibitor--in healthy subjects

1 reference

12 December 2020

Dabigatran versus warfarin in the treatment of acute venous thromboembolism

1 reference

12 December 2020

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism

1 reference

12 December 2020

Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor

1 reference

12 December 2020

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

1 reference

12 December 2020

Interaction revisited: the difference between two estimates

1 reference

12 December 2020

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis

1 reference

12 December 2020

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

12 December 2020

Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation

1 reference

12 December 2020

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.

1 reference

12 December 2020

Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis

1 reference

12 December 2020

Network meta-analysis. Results can be summarised in a simple figure

1 reference

12 December 2020

New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

12 December 2020

Oral rivaroxaban for symptomatic venous thromboembolism

1 reference

12 December 2020

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

1 reference

12 December 2020

Oral apixaban for the treatment of acute venous thromboembolism

1 reference

12 December 2020

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1 reference

12 December 2020

Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials

1 reference

12 December 2020

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

1 reference

12 December 2020

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism

1 reference

12 December 2020

Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor

1 reference

12 December 2020

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

1 reference

12 December 2020

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

12 December 2020

Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism

1 reference

12 December 2020

10.1007/S11239-014-1102-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24989022%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference